Disposable Incontinence Products Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

Description

Persistence Market Research has recently released a detailed report on the global disposable incontinence products market. This report provides an in-depth evaluation of critical market dynamics, including drivers, trends, opportunities, and challenges, offering a thorough understanding of the market structure.

Key Insights:

Disposable Incontinence Products Market Size (2022E): US$ 13.5 million
Projected Market Value (2024F): US$ 22.1 million
Global Market Growth Rate (CAGR 2022 to 2024): 7.3%

Disposable Incontinence Products Market - Report Scope:

Disposable incontinence products are essential for individuals suffering from bladder or bowel control issues, providing comfort and maintaining hygiene. These products are widely used in healthcare settings, home care, and among the geriatric population. The market offers various products, including protective incontinence garments, adult diapers, and pads, which are designed for ease of wear, disposal, and cost-effectiveness. Market growth is driven by the rising prevalence of renal diseases, nephrological injuries, and increasing awareness of care and hygiene.

Market Growth Drivers:

The global disposable incontinence products market is driven by several key factors, including the increased adoption of these products due to heightened awareness of personal care and hygiene. The growing number of patients with diarrhea, bowel disorders, and nerve damage leading to fecal incontinence also contributes to market growth. Additionally, the aging population is a significant driver, with a rising number of elderly individuals experiencing incontinence, thereby boosting the demand for these products. Technological advancements in the materials used for disposable products and catheters further stimulate market expansion.

Market Restraints:

Despite its growth prospects, the disposable incontinence products market faces several challenges. The high cost associated with premium incontinence products and the environmental concerns related to the disposal of these products may hinder market growth. Moreover, cultural stigma and lack of awareness in certain regions could restrain market penetration and adoption rates.

Market Opportunities:

The disposable incontinence products market presents substantial growth opportunities driven by the development of innovative products. Manufacturers are focusing on creating products with increased absorbency, odor control, and breathability to meet the diverse needs of customers. The increasing prevalence of chronic bladder-related diseases and the growing geriatric population also present significant opportunities for market expansion. The adoption of sustainable and eco-friendly materials in product development is another area of opportunity, catering to the environmentally conscious consumer base.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the disposable incontinence products market globally?
Which types of products and applications are leading the demand in various sectors?
How are technological advancements influencing the competitive landscape of the disposable incontinence products market?
Who are the key players in the disposable incontinence products market, and what strategies are they employing to enhance their market presence?
What are the emerging trends and future prospects in the global disposable incontinence products market?

Competitive Intelligence and Business Strategy:

Leading players in the global disposable incontinence products market focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in research and development to enhance product performance, comfort, and customer satisfaction. Collaborations with healthcare providers, retail chains, and online platforms facilitate market access and product adoption. Emphasis on eco-friendly products, sustainability, and customer-centric solutions drives growth and strengthens market positioning in the dynamic disposable incontinence products industry.

Key Companies Profiled:

Svenska Cellulosa Aktiebolaget (SCA)
Becton, Dickinson and Company
ConvaTec Inc
PAUL HARTMANN AG
Medtronic
Unicharm Corporation
Kimberly-Clark Corporation
B. Braun Melsungen AG
Medline Industries, Inc
Theos Medical Systems, Inc.
Fujian Yifa Healthcare Products Co., Ltd
Abena Group
Mega Soft (Fujian) Hygiene Products Co., Ltd
Fujian Hengan Group Ltd
Ontex

Disposable Incontinence Products Market Categorization

Disposable Incontinence Products Market By Material

Plastic
Cotton Fabrics
Super Absorbents
Cotton Fiber
Latex

Disposable Incontinence Products Market By Product Type

Protective Incontinence Garments
Urine Bags
Urinary Catheter

Disposable Incontinence Products Market By Distribution Channel

Institutional Sales
Retail Sales

Disposable Incontinence Products Market By Region

North America
Latin America
Europe
Asia Pacific
Middle East & Africa (MEA)

Product Code: PMRREP11518

1. Executive Summary

1.1. Market Outlook
1.2. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations

3. Market View Point

3.1. Macro-Economic Factors
- 3.1.1. Drivers
- 3.1.2. Restraints
- 3.1.3. Opportunity Analysis
- 3.1.4. Trends

4. Key Inclusions

4.1. U.S.FDA- Regulations for Conventional and Antimicrobial Foley Catheters
4.2. Guidelines for the Prevention of Catheter associated Urinary Tract Infection
4.3. U.S.FDA- Regulations for Urine bags
4.4. U.S.FDA- Regulations for Protective Garments for Incontinence
4.5. Reimbursement Scenario
4.6. PEST Analysis
4.7. Value Chain Analysis

5. Global Disposable Incontinence Products Market- Pricing Analysis

5.1. Regional Pricing Analysis By Product Type
5.2. Global Average Pricing Analysis Benchmark

6. Global Disposable Incontinence Products Market (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2031

6.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
6.2. Current and Future Market Value (US$ Mn) Projections, 2024-2031
- 6.2.1. Y-o-Y Growth Trend Analysis
- 6.2.2. Absolute $ Opportunity Analysis
- 6.2.3. Market Value Comparison

7. Global Disposable Incontinence Products Market Analysis 2019-2023 and Forecast 2024-2031, by Product Type

7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2019-2023
7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2024-2031
7.4. Current and Future Market Volume (Mn Units) Analysis and Forecast By Product Type, 2024-2031
- 7.4.1. Protective Incontinence Garments
  - 7.4.1.1. Cloth Adult Diaper
  - 7.4.1.2. Disposable Adult Diaper
  - 7.4.1.3. Disposable Protective Underwear
  - 7.4.1.4. Disposable Pads and Liners
    - 7.4.1.4.1. Bladder Control Pads
    - 7.4.1.4.2. Male Guards
    - 7.4.1.4.3. Incontinence Liners
  - 7.4.1.5. Belted and Beltless Under Garments
  - 7.4.1.6. Disposable Underpads/Sheet
- 7.4.2. Urine Bags
  - 7.4.2.1. Leg Urine Bags
  - 7.4.2.2. Bedside Urine Bags
- 7.4.3. Urinary Catheter
  - 7.4.3.1. Foley Catheter
  - 7.4.3.2. Intermittent Catheter
  - 7.4.3.3. External Catheter
7.5. Market Attractiveness Analysis By Product Type

8. Global Disposable Incontinence Products Market Analysis 2019-2023 and Forecast 2024-2031, by Raw Material

8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Raw Material, 2019-2023
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Raw Material, 2024-2031
- 8.3.1. Plastic
- 8.3.2. Cotton Fabrics
- 8.3.3. Super Absorbents
- 8.3.4. Cotton Fibres
- 8.3.5. Latex
8.4. Market Attractiveness Analysis By Raw Material

9. Global Disposable Incontinence Products Market Analysis 2019-2023 and Forecast 2024-2031, by Distribution Channel

9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2019-2023
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2024-2031
9.4. Current and Future Market Volume (Mn Units) Analysis and Forecast By Distribution Channel, 2024-2031
- 9.4.1. Institutional Sales
  - 9.4.1.1. Hospitals
  - 9.4.1.2. Long Term Care Centers
  - 9.4.1.3. Nursing Facilities
- 9.4.2. Retail Sales
  - 9.4.2.1. Pharmacy & Drug Stores
  - 9.4.2.2. Home Care
  - 9.4.2.3. Online & E Commerce
9.5. Market Attractiveness Analysis By Distribution Channel

10. Global Disposable Incontinence Products Market Analysis 2019-2023 and Forecast 2024-2031, by Region Type

10.1. Introduction
10.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2023
10.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2024-2031
- 10.3.1. North America
- 10.3.2. Latin America
- 10.3.3. Europe
- 10.3.4. Asia
- 10.3.5. Middle East & Africa
10.4. Market Attractiveness Analysis By Region

11. North America Disposable Incontinence Products Market Analysis 2019-2023 and Forecast 2024-2031

11.1. Introduction
11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
- 11.3.1. By Country
  - 11.3.1.1. U.S.
  - 11.3.1.2. Canada
- 11.3.2. By Product Type
- 11.3.3. By Raw Material
- 11.3.4. By Distribution Channel
11.4. Market Attractiveness Analysis
- 11.4.1. By Country
- 11.4.2. By Product Type
- 11.4.3. By Raw Material
- 11.4.4. By Distribution Channel
11.5. North America Disposable Incontinence Products Market Trends

12. Latin America Disposable Incontinence Products Market Analysis 2019-2023 and Forecast 2024-2031

12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
- 12.3.1. By Country
  - 12.3.1.1. Brazil
  - 12.3.1.2. Argentina
  - 12.3.1.3. Mexico
  - 12.3.1.4. Rest of Latin America
- 12.3.2. By Product Type
- 12.3.3. By Raw Material
- 12.3.4. By Distribution Channel
12.4. Market Attractiveness Analysis
- 12.4.1. By Country
- 12.4.2. By Product Type
- 12.4.3. By Raw Material
- 12.4.4. By Distribution Channel
12.5. Latin America Disposable Incontinence Products Market Trends

13. Europe Disposable Incontinence Products Market Analysis 2019-2023 and Forecast 2024-2031

13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
- 13.3.1. By Country
  - 13.3.1.1. Germany
  - 13.3.1.2. Italy
  - 13.3.1.3. France
  - 13.3.1.4. U.K.
  - 13.3.1.5. Spain
  - 13.3.1.6. Russia
  - 13.3.1.7. Rest of Europe
- 13.3.2. By Product Type
- 13.3.3. By Raw Material
- 13.3.4. By Distribution Channel
13.4. Market Attractiveness Analysis
- 13.4.1. By Country
- 13.4.2. By Product Type
- 13.4.3. By Raw Material
- 13.4.4. By Distribution Channel
13.5. Europe Disposable Incontinence Products Market Trends

14. Asia Pacific Disposable Incontinence Products Market Analysis 2019-2023 and Forecast 2024-2031

14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
- 14.3.1. By Country
  - 14.3.1.1. Japan
  - 14.3.1.2. China
  - 14.3.1.3. India
  - 14.3.1.4. ASEAN
  - 14.3.1.5. Australia & New Zealand
  - 14.3.1.6. Rest of Asia Pacific
- 14.3.2. By Product Type
- 14.3.3. By Raw Material
- 14.3.4. By Distribution Channel
14.4. Market Attractiveness Analysis
- 14.4.1. By Country
- 14.4.2. By Product Type
- 14.4.3. By Raw Material
- 14.4.4. By Distribution Channel
14.5. APAC Disposable Incontinence Products Market Trends

15. Middle East & Africa Disposable Incontinence Products Market Analysis 2019-2023 and Forecast 2024-2031

15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
- 15.3.1. By Country
  - 15.3.1.1. GCC Countries
  - 15.3.1.2. South Africa
  - 15.3.1.3. North Africa
  - 15.3.1.4. Rest of MEA
- 15.3.2. By Product Type
- 15.3.3. By Raw Material
- 15.3.4. By Distribution Channel
15.4. Market Attractiveness Analysis
- 15.4.1. By Country
- 15.4.2. By Product Type
- 15.4.3. By Raw Material
- 15.4.4. By Distribution Channel
15.5. MEA Disposable Incontinence Products Market Trends

16. Competition Analysis

16.1. Competition Dashboard
16.2. Competition Deep Dive
- 16.2.1. Svenska Cellulosa Aktiebolaget (SCA)
  - 16.2.1.1. Overview
  - 16.2.1.2. Drug Portfolio
  - 16.2.1.3. Profitability by Market Segments (Drug/Channel/Region)
  - 16.2.1.4. Sales Footprint
  - 16.2.1.5. Strategy Overview
    - 16.2.1.5.1. Marketing Strategy
    - 16.2.1.5.2. Drug Strategy
    - 16.2.1.5.3. Channel Strategy
- 16.2.2. Becton, Dickinson and Company
  - 16.2.2.1. Overview
  - 16.2.2.2. Drug Portfolio
  - 16.2.2.3. Profitability by Market Segments (Drug/Channel/Region)
  - 16.2.2.4. Sales Footprint
  - 16.2.2.5. Strategy Overview
    - 16.2.2.5.1. Marketing Strategy
    - 16.2.2.5.2. Drug Strategy
    - 16.2.2.5.3. Channel Strategy
- 16.2.3. ConvaTec Inc
  - 16.2.3.1. Overview
  - 16.2.3.2. Drug Portfolio
  - 16.2.3.3. Profitability by Market Segments (Drug/Channel/Region)
  - 16.2.3.4. Sales Footprint
  - 16.2.3.5. Strategy Overview
    - 16.2.3.5.1. Marketing Strategy
    - 16.2.3.5.2. Drug Strategy
    - 16.2.3.5.3. Channel Strategy
- 16.2.4. PAUL HARTMANN AG
  - 16.2.4.1. Overview
  - 16.2.4.2. Drug Portfolio
  - 16.2.4.3. Profitability by Market Segments (Drug/Channel/Region)
  - 16.2.4.4. Sales Footprint
  - 16.2.4.5. Strategy Overview
    - 16.2.4.5.1. Marketing Strategy
    - 16.2.4.5.2. Drug Strategy
    - 16.2.4.5.3. Channel Strategy
- 16.2.5. Medtronic
  - 16.2.5.1. Overview
  - 16.2.5.2. Drug Portfolio
  - 16.2.5.3. Profitability by Market Segments (Drug/Channel/Region)
  - 16.2.5.4. Sales Footprint
  - 16.2.5.5. Strategy Overview
    - 16.2.5.5.1. Marketing Strategy
    - 16.2.5.5.2. Drug Strategy
    - 16.2.5.5.3. Channel Strategy
- 16.2.6. Unicharm Corporation
  - 16.2.6.1. Overview
  - 16.2.6.2. Drug Portfolio
  - 16.2.6.3. Profitability by Market Segments (Drug/Channel/Region)
  - 16.2.6.4. Sales Footprint
  - 16.2.6.5. Strategy Overview
    - 16.2.6.5.1. Marketing Strategy
    - 16.2.6.5.2. Drug Strategy
    - 16.2.6.5.3. Channel Strategy
- 16.2.7. Kimberly-Clark Corporation
  - 16.2.7.1. Overview
  - 16.2.7.2. Drug Portfolio
  - 16.2.7.3. Profitability by Market Segments (Drug/Channel/Region)
  - 16.2.7.4. Sales Footprint
  - 16.2.7.5. Strategy Overview
    - 16.2.7.5.1. Marketing Strategy
    - 16.2.7.5.2. Drug Strategy
    - 16.2.7.5.3. Channel Strategy
- 16.2.8. B. Braun Melsungen AG
  - 16.2.8.1. Overview
  - 16.2.8.2. Drug Portfolio
  - 16.2.8.3. Profitability by Market Segments (Drug/Channel/Region)
  - 16.2.8.4. Sales Footprint
  - 16.2.8.5. Strategy Overview
    - 16.2.8.5.1. Marketing Strategy
    - 16.2.8.5.2. Drug Strategy
    - 16.2.8.5.3. Channel Strategy
- 16.2.9. Medline Industries, Inc
  - 16.2.9.1. Overview
  - 16.2.9.2. Drug Portfolio
  - 16.2.9.3. Profitability by Market Segments (Drug/Channel/Region)
  - 16.2.9.4. Sales Footprint
  - 16.2.9.5. Strategy Overview
    - 16.2.9.5.1. Marketing Strategy
    - 16.2.9.5.2. Drug Strategy
    - 16.2.9.5.3. Channel Strategy
- 16.2.10. Theos Medical Systems, Inc.
  - 16.2.10.1. Overview
  - 16.2.10.2. Drug Portfolio
  - 16.2.10.3. Profitability by Market Segments (Drug/Channel/Region)
  - 16.2.10.4. Sales Footprint
  - 16.2.10.5. Strategy Overview
    - 16.2.10.5.1. Marketing Strategy
    - 16.2.10.5.2. Drug Strategy
    - 16.2.10.5.3. Channel Strategy
- 16.2.11. Fujian Yifa Healthcare Products Co., Ltd
  - 16.2.11.1. Overview
  - 16.2.11.2. Drug Portfolio
  - 16.2.11.3. Profitability by Market Segments (Drug/Channel/Region)
  - 16.2.11.4. Sales Footprint
  - 16.2.11.5. Strategy Overview
    - 16.2.11.5.1. Marketing Strategy
    - 16.2.11.5.2. Drug Strategy
    - 16.2.11.5.3. Channel Strategy
- 16.2.12. Abena Group
  - 16.2.12.1. Overview
  - 16.2.12.2. Drug Portfolio
  - 16.2.12.3. Profitability by Market Segments (Drug/Channel/Region)
  - 16.2.12.4. Sales Footprint
  - 16.2.12.5. Strategy Overview
    - 16.2.12.5.1. Marketing Strategy
    - 16.2.12.5.2. Drug Strategy
    - 16.2.12.5.3. Channel Strategy
- 16.2.13. Mega Soft (Fujian) Hygiene Products Co., Ltd
  - 16.2.13.1. Overview
  - 16.2.13.2. Drug Portfolio
  - 16.2.13.3. Profitability by Market Segments (Drug/Channel/Region)
  - 16.2.13.4. Sales Footprint
  - 16.2.13.5. Strategy Overview
    - 16.2.13.5.1. Marketing Strategy
    - 16.2.13.5.2. Drug Strategy
    - 16.2.13.5.3. Channel Strategy
- 16.2.14. Fujian Hengan Group Ltd
  - 16.2.14.1. Overview
  - 16.2.14.2. Drug Portfolio
  - 16.2.14.3. Profitability by Market Segments (Drug/Channel/Region)
  - 16.2.14.4. Sales Footprint
  - 16.2.14.5. Strategy Overview
    - 16.2.14.5.1. Marketing Strategy
    - 16.2.14.5.2. Drug Strategy
    - 16.2.14.5.3. Channel Strategy
- 16.2.15. Ontex
  - 16.2.15.1. Overview
  - 16.2.15.2. Drug Portfolio
  - 16.2.15.3. Profitability by Market Segments (Drug/Channel/Region)
  - 16.2.15.4. Sales Footprint
  - 16.2.15.5. Strategy Overview
    - 16.2.15.5.1. Marketing Strategy
    - 16.2.15.5.2. Drug Strategy
    - 16.2.15.5.3. Channel Strategy